InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Meyenburg Jason Patrick, Chairman & CEO. Officer active across 2 companies, notably Gemini Therapeutics, Inc. /DE. Aggregated, 2 reports have been logged. Total volume traded: €204k. The latest transaction was filed on 14 May 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€101,78513,000 shares@ €7.8297100.0% of flow
Common Stock
SEC:0000899243-21-019762·
Ideal exit: 8 Feb 2022 (T+270)
€101,78513,000 shares@ €7.8297100.0% of flow
Common Stock
SEC:0000899243-21-019762:0·
Ideal exit: 8 Feb 2022 (T+270)
2 of 2 declarations
About Meyenburg Jason Patrick
Jason Patrick Meyenburg is President and CEO at Gemini Therapeutics, Inc. He is responsible for the strategic direction of the company, focusing on innovation in the field of genetic therapies. Jason Patrick Meyenburg is committed to promoting a corporate culture centered on excellence and accountability.
